Optimizing PCR assays for DNA-based cancer diagnostics.
Somatically acquired DNA rearrangements are characteristic of many cancers. The use of these mutations as diagnostic markers is challenging, because tumor cells are frequently admixed with normal cells, particularly in early stage tumor samples, and thus the samples contain a high background of normal DNA. Detection is further confounded by the fact that the rearrangement boundaries are not conserved across individuals, and might vary over hundreds of kilobases. Here, we present an algorithm for designing polymerase chain reaction (PCR) primers and oligonucleotide probes to assay for these variant rearrangements. Specifically, the primers and probes tile the entire genomic region surrounding a rearrangement, so as to amplify the mutant DNA over a wide range of possible breakpoints and robustly assay for the amplified signal on an array. Our solution involves the design of a complex combinatorial optimization problem, and also includes a novel alternating multiplexing strategy that makes efficient detection possible. Simulations show that we can achieve near-optimal detection in many different cases, even when the regions are highly non-symmetric. Additionally, we prove that the suggested multiplexing strategy is optimal in breakpoint detection. We applied our technique to create a custom design to assay for genomic lesions in several cancer cell-lines associated with a disruption in the CDKN2A locus. The CDKN2A deletion has highly variable boundaries across many cancers. We successfully detect the breakpoint in all cell-lines, even when the region has undergone multiple rearrangements. These results point to the development of a successful protocol for early diagnosis and monitoring of cancer. For online Supplementary Material, see www.liebertonline.com.
Bashir
Ali
A
Department of Computer Science, University of California, San Diego, La Jolla, California 92129, USA.
Lu
Qing
Q
Carson
Dennis
D
Raphael
Benjamin J
BJ
Liu
Yu-Tsueng
YT
Bafna
Vineet
V
D000465:Algorithms; D045744:Cell Line, Tumor; D002869:Chromosome Aberrations; D019457:Chromosome Breakage; D003198:Computer Simulation; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D004273:DNA, Neoplasm / Q000032:analysis* / Q000235:genetics; D019937:Diagnostic Techniques and Procedures; D015321:Gene Rearrangement / Q000235:genetics; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D016133:Polymerase Chain Reaction / Q000379:methods*; D015203:Reproducibility of Results; D013997:Time Factors
D019941:Cyclin-Dependent Kinase Inhibitor p16; D004273:DNA, Neoplasm